Pegylated interferon can control myelodysplastic/myeloproliferative syndrome with ring sideroblasts and thrombocytosis

Autor:	Markus Rechsteiner, Rudolf Benz, Markus G. Manz, Corinne C Widmer, Kathrin Zimmermann, Stefan Balabanov
Přispěvatelé:	University of Zurich, Benz, Rudolf
Rok vydání:	2020
Předmět:	Cancer Research medicine.medical_specialty Provisional diagnosis 2720 Hematology 610 Medicine & health Ring sideroblasts Gastroenterology Polyethylene Glycols 03 medical and health sciences 0302 clinical medicine Pegylated interferon 10049 Institute of Pathology and Molecular Pathology Internal medicine medicine Humans 1306 Cancer Research Thrombocytosis business.industry Myelodysplastic syndromes Hematology medicine.disease Oncology 030220 oncology & carcinogenesis Refractory anemia with ring sideroblasts Myelodysplastic Syndromes 10032 Clinic for Oncology and Hematology 2730 Oncology Interferons business 030215 immunology medicine.drug
Zdroj:	Leukemialymphoma. 61(10)
ISSN:	1029-2403
Popis:	The provisional diagnosis refractory anemia with ring sideroblasts and thrombocytosis was recognized in the WHO 2016 revision of the hematologic neoplasm as a distinct entity and was renamed myelod...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::904f5744843a7d87def9a831b58e66d6 https://pubmed.ncbi.nlm.nih.gov/32449412 Zobrazit plný text záznamu Plný text ve formátu PDF Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.